A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.
about
Chronic Granulomatous Disease; fundamental stages in our understanding of CGDX-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.Chronic granulomatous diseaseNADPH oxidases in lung health and diseaseClinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005-2015): New Studies and a Literature Review.NOX enzymes and pulmonary disease.Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic functionChorioretinal lesions in familial chronic granulomatous disease of childhood.Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood.Gastrointestinal and hepatic manifestations of primary immune deficiency diseases.NADPH oxidase deficiency in X-linked chronic granulomatous diseaseThe role of phagocyte function in resistance to infection.Role of p47phox in antigen-presenting cell-mediated regulation of humoral immunity in mice.Chronic granulomatous disease: a review of the infectious and inflammatory complications.Chronic repetitive suppurations of skin associated with a serum factor affecting bactericidal capacity of polymorphonuclear leukocytes.Host-parasite relationships in patients with dysproteinemias.In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhoodVoltage-Gated Proton Channels as Novel Drug Targets: From NADPH Oxidase Regulation to Sperm BiologyChronic granulomatous disease: quantitative clinicopathological relationshipsDiminished bactericidal capacity for group B streptococci of neutrophils from children with chronic granulomatous disease.Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections.Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease.Energy metabolism of human neutrophils during phagocytosisMechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probesB-cell activating factor (BAFF) is elevated in chronic granulomatous disease.Subcellular distribution of glycosidases in human polymorphonuclear leucocytes.Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycinPhagocytosing human neutrophils inactivate their own granular enzymes.Degranulation deconstructed.NADPH oxidases in traumatic brain injury - Promising therapeutic targets?Considerations in the Diagnosis of Chronic Granulomatous Disease.Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.From Fatal to Chronic Granulomatous Diseases of Childhood.Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease.
P2860
Q21245653-7C535012-ABC1-46C7-AD6B-0FCD012469EEQ24538965-E25B28AD-3931-4DDC-BC71-B10CDEC60965Q27009322-C63A286E-C621-4E27-9775-387FD939821AQ27027435-A0E62DAB-64AE-46CA-BEDB-976CA6381F30Q30235499-461BC35C-F13B-4158-BA26-D94C2329FBC0Q33649864-8C8AE5C3-29BA-415F-9091-3BBEDB2A40FFQ33813874-84C7908E-BECB-4E2D-B19E-E285C0A5A773Q34086541-27E4FC17-13BB-4FFA-A99A-AEDB259A81F8Q34205730-54769B01-AD46-468F-ADA4-554D1D2E3EFFQ34249466-CDB504E0-5E67-40DE-983E-CD73142133B3Q34274894-E8DB6E03-4297-4531-B405-729DB6773733Q34469023-9856EDF8-EC1F-4829-B6EA-EDF2AFF887B3Q34476262-68D7091B-0FEE-4D77-B0AE-EAE270F9C96FQ34769784-8FF12842-630D-4420-A276-C356ADCE3E48Q35072741-6E00069F-4F03-44C4-8DDB-247938122FBFQ35084276-7AE34854-B690-4AEB-BABC-EC577064F4B4Q35142089-F9312CF5-5362-4113-BCAF-71026E7BDE7AQ35540437-8FB13CCE-C8D2-4112-A60E-40301F18B805Q35571700-66591B96-97CA-4480-8EAE-B226BD2DED40Q35977268-3ED932E2-34D4-4956-A1E4-C121AE128733Q36062764-B8B125AB-60B3-485E-B9BC-DF985E2C4134Q36345071-C1AF8A71-3F6B-4174-BAAE-1EAAEAA7654EQ36593591-BC4234C4-40F4-44D7-AC88-FD8BD7A0B0ADQ36965983-7CB21648-D829-42B4-B147-5CCC7BA57D1DQ36985938-4EE8F04C-52A5-4AF0-863A-162CD1930327Q37019090-F21BEAB4-44FB-499C-9C9F-4B07DD274559Q37174792-15AC0CC9-1806-4285-A971-58039733C015Q39211919-E5AC80A3-4C50-4D0E-BB82-DFA93CCD8715Q40435347-435BA56F-5CB7-4059-9FE1-09679B49D5F0Q40683509-F2BC3A17-2F48-4515-BE72-4EF06C1EFBE5Q42113525-509BEF4C-5232-40F7-8A93-412403048DD9Q52344406-72AF60B4-DBFF-413E-9CF4-46AEB40A1C49Q54215574-AE161946-DF5A-49A1-A92F-FF07A5B0DA0CQ54973296-261E2F4F-4195-4371-8F2B-1ECECAAEEEFCQ55005140-90322887-7B3B-4DF1-A3ED-7814BC508AE8Q55385710-D9B24A2C-CC4A-4D56-ADF4-D19ED9AE04A3
P2860
A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.
description
1959 nî lūn-bûn
@nan
1959 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1959 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1959年の論文
@ja
1959年論文
@yue
1959年論文
@zh-hant
1959年論文
@zh-hk
1959年論文
@zh-mo
1959年論文
@zh-tw
1959年论文
@wuu
name
A fatal granulomatous disease ...... ry features of a new syndrome.
@ast
A fatal granulomatous disease ...... ry features of a new syndrome.
@en
A fatal granulomatous disease ...... ry features of a new syndrome.
@nl
type
label
A fatal granulomatous disease ...... ry features of a new syndrome.
@ast
A fatal granulomatous disease ...... ry features of a new syndrome.
@en
A fatal granulomatous disease ...... ry features of a new syndrome.
@nl
prefLabel
A fatal granulomatous disease ...... ry features of a new syndrome.
@ast
A fatal granulomatous disease ...... ry features of a new syndrome.
@en
A fatal granulomatous disease ...... ry features of a new syndrome.
@nl
P2093
P1476
A fatal granulomatous disease ...... ory features of a new syndrome
@en
P2093
P304
P577
1959-04-01T00:00:00Z